(Press-News.org) Researchers have traced in detail how certain powerful HIV neutralizing antibodies evolve, a finding that generates vital clues to guide the design of a preventive HIV vaccine, according to a study appearing in Science Express this week. The discoveries were made by a team led by the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
"This elegant research brings us another step closer to an HIV vaccine and establishes a potent new technique for evaluating the human immune response to experimental vaccines, not only for HIV, but for pathogens generally," said NIAID Director Anthony S. Fauci, M.D.
The new findings build on last year's discovery reported by VRC scientists of three HIV antibodies, two of which could stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory. Called VRC01, VRC02 and VRC03, these antibodies were found in blood donated for NIAID studies by an HIV-infected North American known as donor 45. In the new paper, scientists report discovering antibodies similar to VRC01 in the blood of two HIV-infected Africans known as donor 74 and donor 0219.
The researchers further discovered that these VRC01-like antibodies all bind to the same spot on HIV in the same way. This suggests that an HIV vaccine should contain a protein replica of this spot, known as the CD4 binding site, to elicit antibodies as powerful as VRC01, according to the researchers. The CD4 binding site is one of the few parts of the continuously mutating virus that stays the same across HIV variants worldwide, and the virus uses this site to attach to the cells it infects.
The scientists previously found that the genes for VRC01-like antibodies undergo an unusually high number of mutations—70 to 90—between the first draft that codes for a weak antibody and the final version that codes for an antibody that can neutralize HIV. These genes lie in the DNA of immune cells called B cells.
"To make a vaccine that elicits VRC01-like antibodies, we will need to coach B cells to evolve their antibody genes along one of several pathways, which we have now identified, from infancy to a mature, HIV-fighting form," said VRC Director Gary J. Nabel, M.D., Ph.D.
To guide B cells along this extended evolutionary pathway, the scientists first needed to map the route. They began by turning to an existing technology to sequence the collection of B-cell genes that code for all the antibodies created by a person's immune system. This study marks the first time this technology, called deep sequencing, has been used to track the evolution of the antibody response to HIV at the genetic level. The NIH researchers then devised sophisticated bioinformatics techniques to decipher the large library of genetic data produced by deep sequencing.
"We found a way to read the books, or genes, in this library by defining unique characteristics of VRC01-like antibodies," said Peter Kwong, Ph.D., chief of the VRC's structural biology section and co-principal investigator of the study.
Based on their discovery of the common structure and genetic origin of the VRC01-like antibodies, the scientists devised strategies for scanning the B-cell DNA libraries of donor 45 and donor 74. From hundreds of thousands of antibody genes, the scientists first identified thousands that code for VRC01-like antibodies and then sorted these genes into family trees showing their evolution from their earliest stage into mature forms. The genes that coded for HIV neutralizing antibodies grouped together on the same branches of the trees.
Next, the researchers focused on the gene segment that codes for the part of the VRC01-like antibody that attaches to and neutralizes HIV. Examining this sequence in the genes of the newfound relatives of VRC01 revealed how the sequence changed step by step along one of a few clear paths from its original state into a mature form. A vaccine that elicits VRC01-like antibodies would need to coax the B-cell DNA of immature antibodies to evolve along one of these pathways.
The scientists now aim to create proteins they can deliver through a vaccine to serve as signposts that direct the development of B-cell DNA to produce VRC01-like antibodies.
The new research has far-reaching implications for vaccine development. "As we develop and test new HIV vaccines, it will be possible to analyze not just antibodies in the blood, but also the specific B-cell genes that are responsible for producing antibodies against HIV," said John R. Mascola, M.D., deputy director of the VRC and co-principal investigator of the study. "This information will indicate whether an investigational HIV vaccine in a preclinical or clinical trial is heading in the right direction."
INFORMATION:
Collaborating with the VRC researchers on this study were scientists from the NIH Intramural Sequencing Center, the International AIDS Vaccine Initiative and the NIAID-funded Center for HIV/AIDS Vaccine Immunology.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
Reference:
X Wu et al. Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing. Science Express (online on Aug. 11, 2011).
END
Pasadena, CA— Type Ia supernovae are violent stellar explosions whose brightness is used to determine distances in the universe. Observing these objects to billions of light years away has led to the discovery that the universe is expanding at an accelerating rate, the foundation for the notion of dark energy. Although all Type Ia supernovae appear to be very similar, astronomers do not know for certain how the explosions take place and whether they all share the same origin. Now, a team of researchers has examined new and detailed observations of 41 of these objects and ...
Depressed women may face an increased risk of stroke, according to new research reported in Stroke: Journal of the American Heart Association.
In six years of follow-up of women in the Nurses' Health Study, researchers found that a history of depression was associated with a 29 percent increased risk of total stroke – even after considering other stroke risk factors. Women who used anti-depressant medication — particularly selective serotonin reuptake inhibitors— had a 39 percent increased risk of stroke. Examples of these drugs are Prozac, Zoloft, and Celexa.
Anti-depressant ...
ANN ARBOR, Mich.---A type of fungus that's been lurking underground for millions of years, previously known to science only through its DNA, has been cultured, photographed, named and assigned a place on the tree of life.
Researchers say it represents an entirely new class of fungi: the Archaeorhizomycetes. Like the discovery of a weird type of aquatic fungus that made headlines a few months ago, this finding offers a glimpse at the rich diversity of microorganisms that share our world but remain hidden from view.
The fungal phenomenon, brought to light by researchers ...
The Nobel Prize winning scientists Professor Andre Geim and Professor Kostya Novoselov have taken a huge step forward in studying the wonder material graphene and revealing its exciting electronic properties for future electronic applications.
Writing in the journal Science, the academics, who discovered the world's thinnest material at The University of Manchester in 2004, have revealed more about the electronic properties of its slightly fatter cousin – bilayer graphene.
The researchers, from the universities of Manchester, Lancaster (UK), Nijmegen (the Netherland) ...
Thousands of tonnes of toxic mercury are released into the environment every year. Much of this collects in sediment where it is converted into toxic methyl mercury, and enters the food chain ending up in the fish we eat. New research, published in BioMed Central's open access journal BMC Biotechnology, showcases genetically engineered bacteria which are not only able to withstand high levels of mercury but are also able to mop up mercury from their surroundings.
These mercury-resistant bacteria, developed by researchers from Inter American University of Puerto Rico, ...
(Edmonton, Canada) Access to health care and the usage of emergency departments are popular topics in the news.
David Jones, a graduate student in the University of Alberta's School of Public Health, along with Linda Carroll, professor in the School of Public Health, and Leonard Frank, executive director of the Leduc Beaumont Devon Primary Care Network, recently completed a study that examined whether or not there was a clear association between the number of visits to the emergency department and the availability of an after-hours care clinic in Leduc, Alberta.
Jones ...
After a heart attack or stroke, heart scarring can lead to dangerously paper-thin heart walls and a decreased ability to pump blood through the body. Although the heart is unable to completely heal itself, a new treatment developed at Tel Aviv University uses laser-treated bone marrow stem cells to help restore heart function and health.
Combining the therapeutic benefits of low-level lasers — a process called "shining" — and bone marrow stem cells, Prof. Uri Oron of the Department of Zoology at TAU's George S. Wise Faculty of Life Sciences has developed an effective, ...
A team of researchers from the University of Valladolid (Spain) has analysed 40 brands of beer, discovering that dark beer has more free iron than pale and non-alcoholic beers. Iron is essential to the human diet, but also helps oxidise the organic compounds that give these beverages stability and flavour.
According to the analysis carried out by the University of Valladolid (UVa) on 40 types of beers from all 5 continents, dark beers have an average free iron content of 121 ppb (parts per billion) compared to 92 ppb in pale beers and 63 ppb in non-alcoholic beers.
"Although ...
Milan, Italy, August 11, 2011 – Memory is not a single process but is made up of several sub-processes relying on different areas of the brain. Episodic memory, the ability to remember specific events such as what you did yesterday, is known to be vulnerable to brain damage involving the hippocampus. The question is, what happens when damage to the hippocampus occurs very early in life? In a case study published in the September 2011 issue of Elsevier's Cortex, clinical neuropsychologists have reported that a child can develop normally despite severe damage to the hippocampus ...
Scientists at the National Physical Laboratory (NPL) have mimicked the ways viruses infect human cells and deliver their genetic material. The research hopes to apply the approach to gene therapy – a therapeutic strategy to correct defective genes such as those that cause cancer.
Gene therapy is still in its infancy, with obvious challenges around targeting damaged cells and creating corrective genes. An equally important challenge, addressed by this research, is finding ways to transport the corrective genes into the cell. This is a problem, because of the poor permeability ...
